Archives of Neuroscience

Published by: Kowsar

Relationship Between Anxiety and Depression with Disability Over Multiple Sclerosis Patients in Rafsanjan, Iran

Amir Moghadam Ahmadi 1 , Azam Mobini 2 , Fariba Kabiri 3 , Reza Bidaki 4 , * and Bonnie Bozorg 5
Authors Information
1 Department of Neurology, Rafsanjan University of Medical Sciences, Rafsanjan, IR Iran
2 Islamic Azad University, Yazd Branch, Yazd, IR Iran
3 Islamic Azad University of Khorasgan, Isfahan, IR Iran
4 Department of Psychiatry, Research Center of Addiction and Behavioral Sciences, Shahid Sadoughi University of Medical Sciences, Yazd, IR Iran
5 Tehran University of Medical sciences, Tehran, IR Iran
Article information
  • Archives of Neuroscience: April 2018, 5 (2); e63503
  • Published Online: April 16, 2018
  • Article Type: Research Article
  • Received: April 14, 2017
  • Revised: October 31, 2017
  • Accepted: January 17, 2018
  • DOI: 10.5812/archneurosci.63503

To Cite: Moghadam Ahmadi A, Mobini A, Kabiri F, Bidaki R, Bozorg B. Relationship Between Anxiety and Depression with Disability Over Multiple Sclerosis Patients in Rafsanjan, Iran, Arch Neurosci. 2018 ; 5(2):e63503. doi: 10.5812/archneurosci.63503.

Abstract
Copyright © 2018, Archives of Neuroscience. This is an open-access article distributed under the terms of the Creative Commons Attribution-NonCommercial 4.0 International License (http://creativecommons.org/licenses/by-nc/4.0/) which permits copy and redistribute the material just in noncommercial usages, provided the original work is properly cited
1. Background
2. Methods
3. Results
4. Discussion
Acknowledgements
References
  • 1. Rao SM. Neuropsychology of multiple sclerosis. Curr Opin Neurol. 1995;8(3):216-20. doi: 10.1097/00019052-199506000-00010. [PubMed: 7551121].
  • 2. Amato MP, Ponziani G, Pracucci G, Bracco L, Siracusa G, Amaducci L. Cognitive impairment in early-onset multiple sclerosis. Pattern, predictors, and impact on everyday life in a 4-year follow-up. Arch Neurol. 1995;52(2):168-72. doi: 10.1001/archneur.1995.00540260072019. [PubMed: 7848126].
  • 3. Zhou Y, Simpson SJ, Holloway AF, Charlesworth J, van der Mei I, Taylor BV. The potential role of epigenetic modifications in the heritability of multiple sclerosis. Mult Scler. 2014;20(2):135-40. doi: 10.1177/1352458514520911. [PubMed: 24493701].
  • 4. Burks JS. A review of the current medical aspects of multiple sclerosis. Neurorehabil Neural Repair. 1992;6(3):131-9. doi: 10.1177/136140969200600302.
  • 5. Belbasis L, Bellou V, Evangelou E, Ioannidis JP, Tzoulaki I. Environmental risk factors and multiple sclerosis: an umbrella review of systematic reviews and meta-analyses. Lancet Neurol. 2015;14(3):263-73. doi: 10.1016/S1474-4422(14)70267-4. [PubMed: 25662901].
  • 6. Lincoln JA, Cook SD. An overview of gene-epigenetic-environmental contributions to MS causation. J Neurol Sci. 2009;286(1-2):54-7. doi: 10.1016/j.jns.2009.06.037. [PubMed: 19616791].
  • 7. Handel AE, Williamson AJ, Disanto G, Handunnetthi L, Giovannoni G, Ramagopalan SV. An updated meta-analysis of risk of multiple sclerosis following infectious mononucleosis. PLoS One. 2010;5(9). doi: 10.1371/journal.pone.0012496. [PubMed: 20824132].
  • 8. Handel AE, Williamson AJ, Disanto G, Dobson R, Giovannoni G, Ramagopalan SV. Smoking and multiple sclerosis: an updated meta-analysis. PLoS One. 2011;6(1). e16149. doi: 10.1371/journal.pone.0016149. [PubMed: 21249154].
  • 9. Lin R, Charlesworth J, Stankovich J, Perreau VM, Brown MA, A. NZgene Consortium , et al. Identity-by-descent mapping to detect rare variants conferring susceptibility to multiple sclerosis. PLoS One. 2013;8(3). e56379. doi: 10.1371/journal.pone.0056379. [PubMed: 23472070].
  • 10. Camms Trial Investigators , Coles AJ, Compston DA, Selmaj KW, Lake SL, Moran S, et al. Alemtuzumab vs. interferon beta-1a in early multiple sclerosis. N Engl J Med. 2008;359(17):1786-801. doi: 10.1056/NEJMoa0802670. [PubMed: 18946064].
  • 11. Bagert B, Camplair P, Bourdette D. Cognitive dysfunction in multiple sclerosis: natural history, pathophysiology and management. CNS Drugs. 2002;16(7):445-55. [PubMed: 12056920].
  • 12. Smeltzer S BB. Text Book of Medical-Surgical Nursing. Philadelphia: WB Saunders Co; 2008. p. 242-4.
  • 13. Kingwell E, Marriott JJ, Jette N, Pringsheim T, Makhani N, Morrow SA, et al. Incidence and prevalence of multiple sclerosis in Europe: a systematic review. BMC Neurol. 2013;13:128. doi: 10.1186/1471-2377-13-128. [PubMed: 24070256].
  • 14. Malpass K. Multiple sclerosis: 'Outside-in' demyelination in MS. Nat Rev Neurol. 2012;8(2):61. doi: 10.1038/nrneurol.2011.217. [PubMed: 22249838].
  • 15. Evans C, Beland SG, Kulaga S, Wolfson C, Kingwell E, Marriott J, et al. Incidence and prevalence of multiple sclerosis in the Americas: a systematic review. Neuroepidemiology. 2013;40(3):195-210. doi: 10.1159/000342779. [PubMed: 23363936].
  • 16. Ayatollahi P, Nafissi S, Eshraghian MR, Kaviani H, Tarazi A. Impact of depression and disability on quality of life in Iranian patients with multiple sclerosis. Mult Scler. 2007;13(2):275-7. doi: 10.1177/1352458506070960. [PubMed: 17439899].
  • 17. Kaspper DL, Braunwald E, Fauci A, Hauser SL, Longo D, Jameson JL. Harrison's principles of internal Medical. New York: McGrawhill Compan; 2005. p. 914-7.
  • 18. Zorzon M, de Masi R, Nasuelli D, Ukmar M, Mucelli RP, Cazzato G, et al. Depression and anxiety in multiple sclerosis. A clinical and MRI study in 95 subjects. J Neurol. 2001;248(5):416-21. doi: 10.1007/s004150170184. [PubMed: 11437165].
  • 19. Aloulou J, Hachicha C, Masmoudi R, Boukhris A, Mhiri C, Amami O. P03-528 - Depression, anxiety and multiple sclerosis: Links with alexithymia. Eur Psychiatry. 2011;26:1698. doi: 10.1016/s0924-9338(11)73402-2.
  • 20. Beiske AG, Svensson E, Sandanger I, Czujko B, Pedersen ED, Aarseth JH, et al. Depression and anxiety amongst multiple sclerosis patients. Eur J Neurol. 2008;15(3):239-45. doi: 10.1111/j.1468-1331.2007.02041.x. [PubMed: 18215155].
  • 21. Brajkovic L, Bras M, Milunovic V, Busic I, Boban M, Loncar Z, et al. The connection between coping mechanisms, depression, anxiety and fatigue in multiple sclerosis. Coll Antropol. 2009;33 Suppl 2:135-40. [PubMed: 20120530].
  • 22. Dahl OP, Stordal E, Lydersen S, Midgard R. Anxiety and depression in multiple sclerosis. A comparative population-based study in Nord-Trondelag County, Norway. Mult Scler. 2009;15(12):1495-501. doi: 10.1177/1352458509351542. [PubMed: 19965515].
  • 23. Osborn TM, Sandler NA. The effects of preoperative anxiety on intravenous sedation. Anesth Prog. 2004;51(2):46-51. [PubMed: 15366317].
  • 24. Tsai ST, Chou FH. [The effectiveness of multimedia nursing education on reducing illness-related anxiety and uncertainty in myocardial infarction patients after percutaneous coronary intervention]. Hu Li Za Zhi. 2012;59(4):43-53. doi: 10.6224/JN.59.3.43. [PubMed: 22851393].
  • 25. Beck AT, Steer RA, Carbin MG. Psychometric properties of the Beck Depression Inventory: Twenty-five years of evaluation. Clin Psychol Rev. 1988;8(1):77-100. doi: 10.1016/0272-7358(88)90050-5.
  • 26. Ajorpaz NM, Ezadi A, Heidari S. Comparison of routine education and video CD on anxiety level before general surgery [In Persian]. Qom Univ Med Sci J. 2014;8(5).
  • 27. Kurtzke JF. Rating neurologic impairment in multiple sclerosis: an expanded disability status scale (EDSS). Neurology. 1983;33(11):1444-52. [PubMed: 6685237].
  • 28. Haber A, LaRocca N. Minimal record of disability for multiple sclerosis. New York: National Multiple Sclerosis Society; 1985.
  • 29. Garfield AC, Lincoln NB. Factors affecting anxiety in multiple sclerosis. Disabil Rehabil. 2012;34(24):2047-52. doi: 10.3109/09638288.2012.667503. [PubMed: 23046487].
  • 30. Sarisoy G, Terzi M, Gumus K, Pazvantoglu O. Psychiatric symptoms in patients with multiple sclerosis. Gen Hosp Psychiatry. 2013;35(2):134-40. doi: 10.1016/j.genhosppsych.2012.10.011. [PubMed: 23260339].
  • 31. Dehghani A, Kermanshahi SM, Memarian R, Karimirad MR. Depression and associated demographic factors' correlation in multiple sclerosis patients. Jundishapur J Chronic Dis Care. 2013;2(2):48-55.
  • 32. Juszczak D, Talarowska M, Kowalewski M, Filewski A. [Characteristics of anxiety disorders--prevalence among patients with sclerosis multiple, treatment options and effect on rehabilitation]. Pol Merkur Lekarski. 2009;27(162):532-4. [PubMed: 20120724].
Creative Commons License Except where otherwise noted, this work is licensed under Creative Commons Attribution Non Commercial 4.0 International License .

Search Relations:

Author(s):

Article(s):

Create Citiation Alert
via Google Reader

Readers' Comments